121 related articles for article (PubMed ID: 10983756)
1. High F-18 FDG uptake in a low-grade supratentorial ganglioma: a positron emission tomography case report.
Meyer PT; Spetzger U; Mueller HD; Zeggel T; Sabri O; Schreckenberger M
Clin Nucl Med; 2000 Sep; 25(9):694-7. PubMed ID: 10983756
[TBL] [Abstract][Full Text] [Related]
2. Cerebral gangliogliomas: preoperative grading using FDG-PET and 201Tl-SPECT.
Kincaid PK; El-Saden SM; Park SH; Goy BW
AJNR Am J Neuroradiol; 1998 May; 19(5):801-6. PubMed ID: 9613489
[TBL] [Abstract][Full Text] [Related]
3. The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas.
Gross MW; Weber WA; Feldmann HJ; Bartenstein P; Schwaiger M; Molls M
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):989-95. PubMed ID: 9719107
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of focal cortical dysplasia and mixed neuronal and glial tumors in pediatric epilepsy patients using 18F-FDG and 11C-methionine pet.
Phi JH; Paeng JC; Lee HS; Wang KC; Cho BK; Lee JY; Park SH; Lee J; Lee DS; Kim SK
J Nucl Med; 2010 May; 51(5):728-34. PubMed ID: 20395328
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI.
Vlassenko AG; Thiessen B; Beattie BJ; Malkin MG; Blasberg RG
J Neurooncol; 2000; 46(3):249-59. PubMed ID: 10902856
[TBL] [Abstract][Full Text] [Related]
6. Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion.
Borgwardt L; Højgaard L; Carstensen H; Laursen H; Nowak M; Thomsen C; Schmiegelow K
J Clin Oncol; 2005 May; 23(13):3030-7. PubMed ID: 15860860
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone treatment and plasma glucose levels: relevance for fluorine-18-fluorodeoxyglucose uptake measurements in gliomas.
Roelcke U; Blasberg RG; von Ammon K; Hofer S; Vontobel P; Maguire RP; Radü EW; Herrmann R; Leenders KL
J Nucl Med; 1998 May; 39(5):879-84. PubMed ID: 9591593
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
De Witte O; Levivier M; Violon P; Salmon I; Damhaut P; Wikler D; Hildebrand J; Brotchi J; Goldman S
Neurosurgery; 1996 Sep; 39(3):470-6; discussion 476-7. PubMed ID: 8875476
[TBL] [Abstract][Full Text] [Related]
9. Correlation of FDG-PET interpretation with survival in a cohort of glioma patients.
Pardo FS; Aronen HJ; Fitzek M; Kennedy DN; Efird J; Rosen BR; Fischman AJ
Anticancer Res; 2004; 24(4):2359-65. PubMed ID: 15330185
[TBL] [Abstract][Full Text] [Related]
10. Gangliogliomas: characterization by registered positron emission tomography-MR images.
Provenzale JM; Arata MA; Turkington TG; McLendon RE; Coleman RE
AJR Am J Roentgenol; 1999 Apr; 172(4):1103-7. PubMed ID: 10587156
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of benign vs. malignant mass in a postirradiation cerebral arteriovenous malformation by 2-deoxy-2-[18F] fluoro-D-glucose positron emission tomography.
Raman A; Rothrock JF; Liu HG; Mountz JM
Mol Imaging Biol; 2004; 6(1):1-6. PubMed ID: 15018822
[TBL] [Abstract][Full Text] [Related]
12. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
Li DL; Xu YK; Wang QS; Wu HB; Li HS
Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
[TBL] [Abstract][Full Text] [Related]
13. Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography.
Utriainen M; Metsähonkala L; Salmi TT; Utriainen T; Kalimo H; Pihko H; Mäkipernaa A; Harila-Saari A; Jyrkkiö S; Laine J; Någren K; Minn H
Cancer; 2002 Sep; 95(6):1376-86. PubMed ID: 12216107
[TBL] [Abstract][Full Text] [Related]
14. Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
Kushner BH; Yeung HW; Larson SM; Kramer K; Cheung NK
J Clin Oncol; 2001 Jul; 19(14):3397-405. PubMed ID: 11454888
[TBL] [Abstract][Full Text] [Related]
15. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures.
Pirotte B; Goldman S; Dewitte O; Massager N; Wikler D; Lefranc F; Ben Taib NO; Rorive S; David P; Brotchi J; Levivier M
J Neurosurg; 2006 Feb; 104(2):238-53. PubMed ID: 16509498
[TBL] [Abstract][Full Text] [Related]
16. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
Spence AM; Muzi M; Graham MM; O'Sullivan F; Krohn KA; Link JM; Lewellen TK; Lewellen B; Freeman SD; Berger MS; Ojemann GA
J Nucl Med; 1998 Mar; 39(3):440-8. PubMed ID: 9529289
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive grading of oligodendrogliomas: correlation between in vivo metabolic pattern and histopathology.
Derlon JM; Chapon F; Noël MH; Khouri S; Benali K; Petit-Taboué MC; Houtteville JP; Chajari MH; Bouvard G
Eur J Nucl Med; 2000 Jul; 27(7):778-87. PubMed ID: 10952489
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
19. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
[TBL] [Abstract][Full Text] [Related]
20. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
